Latest news and updates from the Professional, Scientific, and Technical Services sector.
New IBM Power Autonomous Operations software identifies and resolves capacity constraints up to 15x1 faster than manually performing the operation IBM Bob™ Premium Package for i helps accelerate application development on IBM i Entry-level Power S...
IBM CEO Arvind Krishna owned the shortfall that triggered the stock's worst day on record. Tech leaders say candor can build more credibility than trying to spin disappointing news.
Shares in the IT company aren't mounting much of a comeback, as investors reel from Tuesday's brutal selloff.
Investment Thesis
IBM stock suffered its worst one-day decline on record after the technology group admitted that customers were moving money away from its products and towards urgently needed data-centre infrastructure. The stock plunged 25.2% to $217.07 on Tuesda...
IBM's revenue growth slowed to a crawl in Q2 due in large part to hardware costs crowding out software spending. Even after the decline, IBM's total returns have outperformed the S&P 500 during Arvind Krishna's time as CEO.
SAN FRANCISCO, July 15, 2026 /PRNewswire/ -- Hagens Berman (HBSS), a national leader in securities litigation, is actively investigating claims in a securities class action lawsuit against GeneDx Holdings (NASDAQ: WGS) and its executives, alleging...
In the latest trading session, Boston Scientific (BSX) closed at $42.63, marking a -4.52% move from the previous day.
NEW YORK and NEW ORLEANS, July 14, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti , LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 t...
NEW YORK and NEW ORLEANS, July 14, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. (“Erasca” or the “Company”) (NasdaqGS: ERAS)...
IBM investors who relied on the Company's projected Software and Infrastructure segment growth rates and stability faced losses after IBM reported preliminary second-quarter 2026 results and shares fell nearly 25%. NEW YORK, July 14, 2026 /PRNewsw...
SAN FRANCISCO, July 14, 2026 /PRNewswire/ -- Erasca, Inc. (NASDAQ: ERAS) faces a securities class action after the stock tanked $9.25 (-48%) on news that Revolution Medicines (RevMed) accused Erasca of patent infringement concerning Erasca's pan-R...
IBM's stock suffered its worst day in decades. "This quarter we faltered," CEO Arvind Krishna said.
Core Scientific is an electric power contractor for data centers. The company is growing quickly with AI, but is currently burning cash.
'Mad Money' host Jim Cramer talks what is behind IBM's stock price nosedive.
CNBC's Jim Cramer said IBM's sharp sell-off isn't enough to make the stock a buy, as corporate IT spending is shifting away from software toward cybersecurity, hardware and AI tokens. Cramer said IBM still has attractive long-term businesses, but ...
IBM (IBM) closed at $217.07 in the latest trading session, marking a -25.21% move from the prior day.
The stock market rallies again as a profit warning from IBM is offset by tame consumer prices and strong earnings from Goldman Sachs.
The backdrop of IBM (NYSE:IBM) stock falling on Tuesday provided an opportunity for investor Chamath Palihapitiya to share his latest thoughts on the AI sector and heavy spending leading to potential risks down the road.
IBM is in free fall.
Today, July 14, 2026, customers redirected IT budgets away from software and infrastructure, raising questions about near-term demand durability.
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ: WGS). Such investors are advised to contact Danielle Peyton at new...
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ: ERAS). Such investors are advised to contact Danielle Peyton at newaction@p...
Shares of the corporate stalwart plunged 25% as AI purchases crowd out traditional tech spending in many companies' budgets.
The company said the shortfall in its software and infrastructure business was tied to clients spending on memory ahead of price hikes.
CNBC Business News Update with Jessica Ettinger - Markets & Business News With Expert Analysis From Top Business Names. Visit CNBC.com For More.
Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec. -------- More on Bloomberg Television and Markets Like this v...
“When we discussed our expectations with you in April, we noted that we would be wrapping on the launch of z17 in the second quarter. Given this was the strongest start to a mainframe program in our history, we expected Infrastructure revenue to d...
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”), o...
Erasca Inc. (NASDAQ:ERAS) reported updated preliminary Phase 1 data for its investigational pan-RAS molecular glue ERAS-0015, citing encouraging early activity in RAS-mutant solid tumors while outlining plans to advance the candidate into potentia...